In triple-negative breast cancer cells, treatment with N41mab-vcMMAE comprising a human anti-nectin-4 monoclonal antibody conjugated to monomethyl auristatin-E (MMAE) resulted in inhibition of cell proliferation in vitro and reduced metastasis in vivo [58]. This evidence concerns the gene NECTIN4 and triple-negative breast carcinoma.